British Association of Surgical Oncology Guidelines: The management of metastatic bone disease in the United Kingdom
- 28 February 1999
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 25 (1), 3-23
- https://doi.org/10.1053/ejso.1998.0593
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- The objective measurement of remission and progression in metastatic breast cancer by use of serum tumour markersEuropean Journal Of Cancer, 1999
- Opioid rotation: does it have a role?Palliative Medicine, 1997
- Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking studyCancer, 1994
- Subjective and metabolic effects of clodronate in patients with advanced breast cancer and symptomatic bone metastasesAnti-Cancer Drugs, 1992
- A double-blind, crossover trial of intravenous clodronate in metastatic bone painJournal of Pain and Symptom Management, 1992
- An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to boneBone, 1991
- Metastatic Disease in Long Bones A Proposed Scoring System for Diagnosing Impending Pathologic FracturesClinical Orthopaedics and Related Research, 1989
- Current Considerations in the Management of Neoplastic Spinal Cord CompressionSpine, 1989
- QUANTITATIVE OESTRADIOL RECEPTOR VALUES IN PRIMARY BREAST CANCER AND RESPONSE OF METASTASES TO ENDOCRINE THERAPYThe Lancet, 1981
- Indications for nonoperative treatment of spinal cord compression due to breast cancerJournal of Neurosurgery, 1977